Page last updated: 2024-11-04

sulpiride and Osteoporosis, Postmenopausal

sulpiride has been researched along with Osteoporosis, Postmenopausal in 2 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgante, G1
Farina, M1
Cianci, A1
La Marca, A1
Petraglia, F1
De Leo, V1
Marzo-Castillejo, M1
Alonso-Coello, P1

Trials

1 trial available for sulpiride and Osteoporosis, Postmenopausal

ArticleYear
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:4

    Topics: Bone Density; Drug Administration Schedule; Drug Therapy, Combination; Endometrium; Female; Hot Flas

2004

Other Studies

1 other study available for sulpiride and Osteoporosis, Postmenopausal

ArticleYear
[Clinical guide to the menopause and post-menopause].
    Atencion primaria, 2005, Sep-30, Volume: 36, Issue:5

    Topics: Aged; Female; Fractures, Bone; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Postmen

2005